Market

Vertex reports promising 48-week data for povetacicept in kidney diseases

Vertex reports promising 48-week data for povetacicept in kidney diseases
Read More

Related Posts

Enanta Pharma chief medical officer sells $11k in stock

Enanta Pharma chief medical officer sells $11k in stock

I tried to donate my crypto to charity. Here’s what I learned.

I tried to donate my crypto to charity. Here’s what I l...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

Two of Brazil’s nine central bank seats likely to be unfilled at January meeting, sources say

Two of Brazil’s nine central bank seats likely to be un...

This crazy chart shows just how much cash OpenAI is burning as it chases AI profits

This crazy chart shows just how much cash OpenAI is bur...